Tor Ny

Umeå Biotech Incubator AB is a biotechnical research and development company based in Umeå, Sweden. Part of Umea Universitet, Umeå Biotech Incubator AB engages in biotechnical research and development business. The CEO of the Swedish company is Tor Ny.

Omnio Healer AB is a company developing novel drug candidates based on a series of conceptual breakthroughs in inflammation research. This new, pro-inflammatory approach opens up completely new therapeutic strategies for wound healing and anti-infection. The company's lead drug candidate, aimed primarily at otological indications, has achieved promising preclinical results and will enter a clinical development program in late 2010. Since its foundation in 2006 Omnio Healer has assembled a management and development team. This includes scientists within the field, experienced product development professionals and active investors led by Karolinska Development AB, providing access to a network of biotechnology development resources. The company is based in Umeå, Sweden.